UCI Health, the clinical enterprise of the University of California, Irvine, is conducting a first-in-human, Phase I clinical trial using laser light to target localized but inoperable pancreatic tumors to help patients become cancer-free.

Adelaide University researchers have developed a new way to use mRNA technology to reprogram tumor-supporting immune cells and strengthen the body’s anticancer immune response.

Columbia University researchers have identified a way to help predict when people at high risk of developing Alzheimer’s are likely to develop their first symptoms, a finding that could help physicians decide when to prescribe preventive treatments currently in development.

A family of nanoparticles—tiny, biodegradable molecules commonly used to deliver drugs to patients—shows promise in treating Alzheimer’s disease without additional medication, according to new research from a University of Alberta neuroscientist.